Isomorphic Labs, the AI-powered drug discovery company spun out of Google DeepMind, is reportedly in advanced talks to raise more than $2 billion in fresh funding.
According to reports, venture capital firm Thrive Capital, which led the company’s first funding round last year, is expected to lead the new investment round as well. Alphabet, Google’s parent company, is also expected to participate in the funding. However, the deal has not been finalised yet.
The London-based company is among a growing number of firms using artificial intelligence to speed up drug discovery, improve research efficiency and reduce development costs in the healthcare sector. The industry has seen rising interest in applying AI models to life sciences, even as many earlier attempts by technology firms faced challenges.
Isomorphic Labs was formed in 2021 after spinning out from Google DeepMind. The company was created to explore the commercial applications of AlphaFold, the AI system designed to predict protein structures. DeepMind CEO Demis Hassabis also leads Isomorphic Labs, with the company recruiting several experts from its parent AI division.
Reports suggest the new funding will help strengthen the company’s drug design engine and support its global expansion plans.
The company has already partnered with major pharmaceutical firms including Johnson & Johnson and Eli Lilly & Co. It has also expanded its collaboration with Novartis to accelerate AI-based drug research initiatives.
The development highlights Alphabet’s broader strategy of building futuristic technology ventures into independent businesses. Alongside Isomorphic Labs, Alphabet has backed several major AI-focused companies and startups, including autonomous driving firm Waymo, Anthropic and SpaceX.
The increasing flow of investments into AI healthcare startups reflects growing confidence that artificial intelligence could reshape pharmaceutical research, drug development and medical innovation in the coming years.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream LinkedIn | The Mainstream Facebook | The Mainstream Youtube | The Mainstream Twitter
About us:
The Mainstream is a premier platform delivering the latest updates and informed perspectives across the technology business and cyber landscape. Built on research-driven, thought leadership and original intellectual property, The Mainstream also curates summits & conferences that convene decision makers to explore how technology reshapes industries and leadership. With a growing presence in India and globally across the Middle East, Africa, ASEAN, the USA, the UK and Australia, The Mainstream carries a vision to bring the latest happenings and insights to 8.2 billion people and to place technology at the centre of conversation for leaders navigating the future.
